$ARAT
Arax Holdings Corp

2022 Q3 Form 10-Q Financial Statement

#000175392622001266 Filed on September 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.12K $13.05K $23.62K
YoY Change -24.46% -85.98% 85.69%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.12K $13.05K $23.62K
YoY Change -24.44% -85.98% 85.69%
Operating Profit -$11.12K -$13.05K -$23.62K
YoY Change -24.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$11.12K -$13.05K -$23.62K
YoY Change -24.44% -85.98% 85.69%
Income Tax
% Of Pretax Income
Net Earnings -$11.12K -$13.05K -$23.62K
YoY Change -24.44% -85.98% 85.69%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$1.076K -$1.263K -$2.285K
COMMON SHARES
Basic Shares Outstanding 10.34M shares
Diluted Shares Outstanding 10.34M shares 10.34M shares 10.34M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $23.62K $12.50K $16.02K
YoY Change 60.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $73.80K $62.68K $49.63K
YoY Change 401.34% 984.43% 290.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $73.80K $62.68K $49.63K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $73.80K $62.68K $49.63K
YoY Change 401.34% 984.43% 290.17%
SHAREHOLDERS EQUITY
Retained Earnings -$778.2K -$754.0K
YoY Change 8.22%
Common Stock $10.34K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$73.80K -$62.68K -$49.63K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$11.12K -$13.05K -$23.62K
YoY Change -24.44% -85.98% 85.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 0.000 0.000
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000
Net Change In Cash 0.000 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Assets
Assets
usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2021Q3 us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
dei City Area Code
CityAreaCode
564
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001566243
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2022Q3 us-gaap Assets
Assets
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q3 ARAT Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
CY2021Q3 ARAT Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
ARAT Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
usd
ARAT Stock Based Compensation
StockBasedCompensation
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
ARAT Forgiveness Of Related Party Debt Credited To Paid In Capital
ForgivenessOfRelatedPartyDebtCreditedToPaidInCapital
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-185928
dei Entity Registrant Name
EntityRegistrantName
ARAX HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0376721
dei Entity Address Address Line1
EntityAddressAddressLine1
30 N Gould Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
dei Local Phone Number
LocalPhoneNumber
234-7009
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10335294 shares
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23622 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14150 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
50175 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
11862 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
73797 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26012 usd
CY2022Q3 us-gaap Liabilities
Liabilities
73797 usd
CY2021Q4 us-gaap Liabilities
Liabilities
26012 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335294 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335294 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335294 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335294 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
10335 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
10335 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
684046 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
684046 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-778178 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-730393 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-73797 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-26012 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11122 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14720 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47785 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14720 usd
ARAT Administrative Expenses Related Party
AdministrativeExpensesRelatedParty
105775 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
11122 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
14720 usd
us-gaap Operating Expenses
OperatingExpenses
47785 usd
us-gaap Operating Expenses
OperatingExpenses
120495 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11122 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14720 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-47785 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-120495 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11122 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14720 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47785 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-120495 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-11122 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-14720 usd
us-gaap Profit Loss
ProfitLoss
-47785 usd
us-gaap Profit Loss
ProfitLoss
-120495 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335294 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335294 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335294 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10335294 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-26012 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23616 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49628 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13047 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-62675 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-11122 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-73797 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12721 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-12721 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-93054 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5775 usd
CY2021Q3 ARAT Forgiveness Of Debt Treated As A Capital Contribution
ForgivenessOfDebtTreatedAsACapitalContribution
5775 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14720 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-14720 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47785 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-120495 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38313 usd
ARAT Stock Based Compensation
StockBasedCompensation
83834 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9472 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14720 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21941 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21941 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21941 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
16166 usd
ARAT Forgiveness Of Related Party Debt Credited To Paid In Capital
ForgivenessOfRelatedPartyDebtCreditedToPaidInCapital
5775 usd
CY2022Q3 ARAT Working Capital Deficit
WorkingCapitalDeficit
-73797 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-778178 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_z3T3RqYHfco" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_865_zAJQs6lM8S62">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2021Q1 ARAT Common Stock Issued For Loan And Compensation Expenses
CommonStockIssuedForLoanAndCompensationExpenses
100000 usd
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
16166 usd
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
83834 usd
CY2022Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
50175 usd
CY2021Q4 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
11862 usd

Files In Submission

Name View Source Status
0001753926-22-001266-index-headers.html Edgar Link pending
0001753926-22-001266-index.html Edgar Link pending
0001753926-22-001266.txt Edgar Link pending
0001753926-22-001266-xbrl.zip Edgar Link pending
arat-20220630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g083181_10q.htm Edgar Link pending
g083181_ex31-1.htm Edgar Link pending
g083181_ex31-2.htm Edgar Link pending
g083181_ex32-1.htm Edgar Link pending
g083181_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
arat-20220630_pre.xml Edgar Link unprocessable
arat-20220630_def.xml Edgar Link unprocessable
arat-20220630_cal.xml Edgar Link unprocessable
arat-20220630_lab.xml Edgar Link unprocessable
g083181_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending